These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2198122)
81. [Purification of immunoglobulin for intravenous administration from heme pigment and chorionic gonadotropin]. Anastasiev VV; Kiseleva IA; Sergeeva IV; Savkina MA; Taraeva GA Gematol Transfuziol; 1986 Jun; 31(6):60-2. PubMed ID: 3732783 [No Abstract] [Full Text] [Related]
82. Human immunoglobulins in therapy. Rationale and clinical applications. Dammacco F; Campobasso N; Perosa F Ric Clin Lab; 1983; 13(2):183-202. PubMed ID: 6622925 [No Abstract] [Full Text] [Related]
83. [Immunoglobulins: multiple potential therapeutic proteins for use in immune deficits]. Adoue D; Grivel T Rev Med Interne; 2010 Dec; 31(9 Suppl):H9-11. PubMed ID: 20965374 [No Abstract] [Full Text] [Related]
84. 7th International Immunoglobulin Conference: Foreword. Jolles S; Jordan SC; Orange JS; van Schaik IN Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):1-2. PubMed ID: 25695109 [No Abstract] [Full Text] [Related]
85. Somebody else's antibodies: the characteristics and roles of immune globulins. Grabenstein JD Pharm Pract Manag Q; 2001; 20(3):41-55; quiz 56-9. PubMed ID: 11291518 [TBL] [Abstract][Full Text] [Related]
86. Passively acquired human immunodeficiency virus seropositivity in a neonate after hepatitis B immunoglobulin. Albersheim SG; Smyth JA; Solimano A; Cook D J Pediatr; 1988 Jun; 112(6):915-6. PubMed ID: 3373398 [No Abstract] [Full Text] [Related]
87. Injectable immunoglobulins, immunodeficiency and off-label clinical trials, source plasma and ethical concerns and debates. Garraud O Transfus Apher Sci; 2019 Aug; 58(4):529-530. PubMed ID: 31256945 [No Abstract] [Full Text] [Related]
88. [Production of immunoglobulin for intravenous injection from donor blood plasma]. Anastasiev VV; Kiseleva IA; Novikova LP; Taraeva GA Gematol Transfuziol; 1985 Oct; 30(10):46-8. PubMed ID: 4065524 [No Abstract] [Full Text] [Related]
89. Managing the shortage of intravenous immune globulin. Decker EL; Gouveia WA Am J Health Syst Pharm; 1998 Oct; 55(20):2090, 2093. PubMed ID: 9988567 [No Abstract] [Full Text] [Related]
90. Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16. Goudouris ES; Silva AMDR; Ouricuri AL; Grumach AS; Condino-Neto A; Costa-Carvalho BT; Prando CCM; Kokron CM; Vasconcelos DM; Tavares FS; Segundo GRS; Barreto ICDP; Dorna MB; Barros MAMT; Forte WCN Einstein (Sao Paulo); 2017; 15(4):522. PubMed ID: 29364371 [No Abstract] [Full Text] [Related]
91. Immunoglobulins, a short overview of an international symposium held in Amsterdam, March 14-16, 1988. Strengers PF; van Aken WG Biotherapy; 1989; 1(2):117-22. PubMed ID: 2701501 [No Abstract] [Full Text] [Related]
92. Recent advances in intravenous immunoglobulin therapy: Concluding remarks. Current trends and future directions. Desai RG Cancer; 1991 Sep; 68(6 Suppl):1460-4. PubMed ID: 1878845 [No Abstract] [Full Text] [Related]
93. Effects of intravenous gamma-globulin in pemphigus. Humbert P; Derancourt C; Aubin F; Agache P J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):326. PubMed ID: 2312826 [No Abstract] [Full Text] [Related]
95. Comment on undegraded human 7S-immunoglobulin for intravenous use. Wadsworth C Vox Sang; 1976 Nov; 31(5):394-400. PubMed ID: 1007163 [No Abstract] [Full Text] [Related]
96. [Expert consensus on immunoglobulin G replacement therapy in primary immunodeficiency disease]. ; Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):909-912. PubMed ID: 31795555 [TBL] [Abstract][Full Text] [Related]